开发用于X连锁疾病无创产前诊断的通用平台
本研究设计了一个靶向33个基因和重组热点的定制捕获探针,对6个家系的携带者母亲和男性先证者进行检测,并在不同孕周采集母亲血浆DNA测序,通过估计两种母源单倍型之间的不平衡来确定胎儿基因型,6个家系的胎儿基因型均被正确预测。
要点
- 定制捕获探针靶向33个基因和重组热点,在目标区域获得均匀覆盖。
- 每个样本中观察到3至5个重组点,但不影响胎儿基因型预测的单倍型剂量分析。
- 6个家系中所有胎儿基因型均通过母体血浆测序数据的单倍型剂量分析被正确预测。
核心结论
- 覆盖多种疾病的单一平台可能避免针对单个疾病的无创产前诊断需要疾病特异性探针,该方法可能为临床实施X连锁疾病的无创产前诊断提供实用优势。
研究设计与样本
- 研究设计了靶向33个基因和重组热点的定制捕获探针,检测了6个家系的携带者母亲和男性先证者配对。
- 在不同孕周采集 pregnant carrier mother 的血浆DNA并测序。
- 通过估计使用通用定制平台构建的两种母源单倍型之间的不平衡来确定每个家系的胎儿基因型。
主要发现
- 对母体、先证者和胎儿基因组DNA及母体血浆DNA的靶向测序在目标区域获得均匀覆盖。
- 每个样本中观察到3至5个重组点,但这些重组点不影响胎儿基因型预测的单倍型剂量分析。
- 6个家系中所有胎儿基因型均通过母体血浆测序数据的单倍型剂量分析被正确预测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to develop a common targeted massively parallel sequencing platform for the noninvasive prenatal diagnosis (NIPD) of multiple X-linked diseases. METHOD: The custom capture probe was designed to target 33 genes and recombination hotspots. We tested the carrier mother and male proband pair of 6 families. Plasma DNA of the pregnant carrier mother was collected at different gestational weeks and sequenced. The fetal genotype of each family was determined by estimating the imbalance between the 2 maternal haplotypes constructed using a common custom-designed platform. RESULTS: The targeted sequencing of the maternal, proband, and fetal genomic DNAs and maternal plasma DNAs resulted in uniform coverage across the target region. Three to 5 recombination points were observed in each sample. However, these recombination points did not affect the haplotype dosage analysis for fetal genotype prediction. Consequently, all fetal genotypes in the 6 families obtained from haplotype dosage analysis of maternal plasma sequencing data were predicted correctly. CONCLUSIONS: Since a single platform that covers multiple diseases may prevent the need for disease-specific probes for the NIPD of individual disorders, this approach may provide a practical advantage for clinically implementing the NIPD of X-linked diseases.
引用
- Jang SS, Lim BC, Yoo SK, et al. Development of a common platform for the noninvasive prenatal diagnosis of X-linked diseases. Prenat Diagn. 2018. PMID: 30048567. doi:10.1002/pd.5337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。